H.R. 4332 (112th): Generic Drug Application Review Fairness Act of 2012


Mar 29, 2012
112th Congress, 2011–2013

Died in a previous Congress

This bill was introduced on March 29, 2012, in a previous session of Congress, but was not enacted.


Frank Pallone Jr.

Representative for New Jersey's 6th congressional district



Read Text »
Last Updated: Mar 29, 2012
Length: 7 pages

About the bill

Full Title

To amend section 505(j) of the Federal Food, Drug, and Cosmetic Act to extend the period for a first applicant, with respect to a generic drug, to obtain tentative approval without forfeiting the 180-day exclusivity period, and for other purposes.

Summary (CRS)

3/29/2012--Introduced.Generic Drug Application Review Fairness Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act to extend from 30 to 60 months after application the period for a ... Read more >

The bill’s title was written by its sponsor.


Mar 29, 2012

This is the first step in the legislative process.

This is a House of Representatives bill in the United States Congress (indicated by the “H.R.” in “H.R. 4332”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.


6 cosponsors (3R, 3D) (show)
Committee Assignments

The committee chair determines whether a bill will move past the committee stage.


There have been no roll call votes related to this bill.

Related Bills

Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.

H.R. 5651 (Related)
Food and Drug Administration Reform Act of 2012

Passed House
Last Action: May 30, 2012

Search for similar bills.

Links & tools

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Click a format for a citation suggestion: